drugset / Trial / NCT04386811

Vitamin D as a Therapeutic Adjunct in the Stimulant Treatment of ADHD: a Proof-of-concept Tele-health Study of Stimulant-induced Improvement in Neurocognitive Functioning.

NCT04386811 ↗

Phase 1 Terminated 3 enrolled Yale University
RandomizedCrossoverSingle-blindTreatment

Summary

The purpose of this study is to assess vitamin D as a therapeutic adjunct in the stimulant treatment of ADHD.

Timeline

Start
2020-08-05
Primary completion
2020-09-29
Completion
2020-09-29

Outcome

Outcome not reported

Stopped (Business): “Following Yale University resuming in-person research activities, the investigators no longer had dedicated funding for the study and were unable to secure additional funding to meet the research goals.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Calcitriol Small molecule — —